AcademicCME Podcast

Updating the Efficacy and Safety Experience of IL-17 Inhibitors

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies

Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD

Therapeutic Update on COPD with Type 2 Inflammation

Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making

AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis

ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function

Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

Clinical Trial Data Review for PBC Therapeutics

PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment

VTE and Anticoagulation - Guideline Updates for 2024

Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE

Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

Part 1: Advances in Patient-Actuated Treatment for PSVT

Part 2: Advances in Patient-Actuated Treatment for PSVT

Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies

Hyperkalemia 3: Clinical Trial Update for Newer Therapeutic Options to Treat Hyperkalemia

Hyperkalemia Part 2: Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia

Hyperkalemia Part 1: Review the Science of Recurrent Hyperkalemia, Including Relationships Between Dietary Potassium Intake, Serum Potassium, and Patient Morbidities

Avances en el tratamiento de la ERC con inhibidores de SGLT2 en pacientes con y sin diabetes: el ensayo EMPA-KIDNEY

Kombinationstherapie der chronischen Nierenerkrankung: Die EMPA-Kidney Studie

EMPA-Kidney: la révolution de la néphroprotection par les inhibiteurs SGLT-2 est là

Advances in Slowing the Progression of CKD with SGLT2 Inhibitors

NTM Series Ep. 5: Evaluation of Clinical Data on NTM‐LD Therapeutics and Management

NTM Series Ep. 4: Diagnostic Stratgies and Long-Term Management of Patients with NTM-LD

NTM Series Ep. 3: Clinical Trial Update: ATS 2022

NTM Series Ep. 2: Improving Adherence and Outcomes While Reducing the Risk of Drug-Related Toxicity

NTM Series Ep. 1: Adapting Treatment Goals Based on Patient Needs

Part 2: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies

Part 1: Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies

Advances in Fumarate-based Therapeutics to Improve Outcomes in Patients with Multiple Sclerosis

Clinical Trial Update: MSVirtual 2020 (Multiple Sclerosis Podcast Series EP. 1)

Alzheimer’s Education for Patients and Care Givers: Strategies for Shared-Decision Making (Alzheimer's Disease Podcast Series Ep. 6)

Advances in Neuroimaging and Technology for AD Detection and Management (Alzheimer's Disease Podcast Series Ep. 5)

The Role of Genetics and Mechanisms of Synaptic Dysfunction (Alzheimer's Disease Podcast Series Ep. 4)

Early Diagnosis and Biomarkers in Alzheimer’s Disease (Alzheimer’s Disease Podcast Series Ep. 3)

Clinical Trial Data Review & Analyses: AAIC 2020 (Alzheimer's Disease Podcast Series Ep. 2)